Hospital Universitario La Paz: Observational study in Hepatocellular Carcinoma (HCC) (417 participants)
Hospital Universitario La Paz: Observational study in Hepatocellular Carcinoma (HCC) (417 participants). Its enrollment of 417 is above the median of 80 (87th percentile). Dated 23 days ago, it is in the active follow-up window. Score 30/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 417 · 87th percentile of 8,879 ClinicalTrialStartPulse records · 5.2x the median
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Hospital Universitario La Paz |
| Sponsor type | Academic and hospital |
| Study | Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort. |
| NCT ID | NCT07872319 |
| Phase | Observational |
| Status | completed |
| Conditions | Hepatocellular Carcinoma (HCC) |
| Target enrollment | 417 |
| Site countries | Spain |
| Posted | 2026-10-13 |
| Planned start | 2022-02-02 |
| Event | Newly registered study |
| Event date | 2026-10-13 |
| enrollment percentile | 87th of 8,879 (median 80, 5.2x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Hospital Universitario La Paz
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Hospital Universitario La Paz + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-13
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Hospital Universitario La Paz and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Hospital Universitario La Paz's enrollment: 87th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
30 / 100 Score
- 417 participants planned.
What is the ClinicalTrialStartPulse record for Hospital Universitario La Paz?
Hospital Universitario La Paz registered a Observational study (NCT07872319) in Hepatocellular Carcinoma (HCC) targeting 417 participants, posted 2026-10-13.
How does Hospital Universitario La Paz compare to other ClinicalTrialStartPulse records?
Its enrollment of 417 sits in the upper half (87th percentile) of 8,879 records; the median is 80. It is 23 days old, still within a typical 45-day follow-up window. Its Score of 30/100 is modest; treat it as background rather than a priority.
Hospital Universitario La Paz vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Hospital Universitario La Paz | NONUS | 417 | 87th | 2026-10-13 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | NONUS | 366 | 85th | 2026-11-03 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
| Teva Branded Pharmaceutical Products R&D LLC | NONUS | 1,085 | 95th | 2026-11-03 |
Related records
- Calyxo, Inc.
- Hoffmann-La Roche
- Restor3D
- Kardium Inc.
- Janssen Biotech, Inc.
- Janssen Scientific Affairs, LLC
- Ethicon Endo-Surgery
- Janssen Pharmaceutica N.V., Belgium
- Janssen-Cilag International NV
- Janssen Biotech, Inc.
- Teva Branded Pharmaceutical Products R&D LLC
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Hospital Universitario La Paz and peer observational records
Get new ClinicalTrialStartPulse records like Hospital Universitario La Paz by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.